A Modified BPaL Regimen for Tuberculosis Treatment replaces Linezolid with Inhaled Spectinamides
M. Zohaib Ali, T. S. Dutt, A. MacNeil, A. Walz, J. Patterson, C. Pearce, H. Lam, J. S. Philp, R. Lee, J. Liu, G. T. Robertson, A. J. Hickey, B. Meibohm, M. Gonzalez-Juarrero
This paper evaluates a modified BPaL regimen replacing linezolid with inhaled spectinamide 1599 for tuberculosis treatment, showing similar efficacy while avoiding linezolid-associated adverse events.
bioRxiv · Nov 16, 2023Microbiology